Csl Ltd has released a press release.
CSL to acquire LateStage Gene Therapy Candidate from uniQure
Filed with ASX ·
Watch CSL's latest callCSL (ASX:CSL) Q4 2026 Earnings Call · Replay · Aug 18Read the transcript of CSL (ASX:CSL) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from CSL
- Change in Leadership of CSLs Finance Function
- New Debt Facilities to Strengthen Maturity Profile
- CSL Statutory Accounts for the Half Year Ended 31/12/2019
- Research and Development Investor Briefing 2019
- CSL Full Year Statutory Accounts for the Year Ended 30/06/19
Later from CSL
- Statutory Accounts for the Full Year Ended 30 June 2020
- CSL Supply Agreement for UQ Vaccine with Commonwealth
- Chairmans Address to Shareholders
- Update on UQ-CSL v451 COVID-19 Vaccine
- Dividend/Distribution - CSL
Follow CSL into a list and get an email when it puts out news.
Follow CSL